Showing results (21-30 of 256) with videos related to
Sort By:
Pageof 26
Anticancer Research|April 13, 2001
Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in miceY Saegusa, M Eriguchi, Y Kidani, et al.Chemical & Pharmaceutical Bulletin|February 1, 1992
Zinc deficient bovine erythrocyte superoxide dismutase has low specific activityJ Hirose, H Kano, Y Kidani, et al.Annals of the New York Academy of Sciences|May 12, 2018
Neural mechanisms of the link between giving social support and healthTristen K InagakiCancer Research|September 1, 1983
Preferential inhibition of the activity of a stimulatory protein of eukaryotic transcription by platinum (II) complexesN Matsumoto, K Sekimizu, M Horikoshi, et al.Journal of Inorganic Biochemistry|September 1, 1990
The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG)E L Lempers, M J Bloemink, J Brouwer, et al.Biochemistry International|March 1, 1984
Selective binding behavior of zinc(II) and copper(II) ions to their native sites of apo-bovine superoxide dismutaseJ Hirose, M Yamada, C Hayakawa, et al.Biological & Pharmaceutical Bulletin|October 1, 1993
Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligandT Yamashita, J Hirose, M Noji, et al.Chemical & Pharmaceutical Bulletin|February 1, 1995
Reaction of (1R,2S,3S)-3-methylcyclohexanediamineplatinum(II) with DNA: isolation and characterization of the platinum-nucleotide adducts by means of HPLC and NMR spectroscopyK Inagaki, K SawakiChild Development|October 1, 1993
Young children's understanding of the mind-body distinctionK Inagaki, G HatanoPageof 26